Dr. Troy Potter, MD
What this data tells you about Dr. Potter
Dr. Troy Potter is an internal medicine specialist in Texarkana, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Potter performed 16,526 Medicare services across 6,253 unique beneficiaries.
Between the years covered by Open Payments, Dr. Potter received a total of $2,885 from 33 pharmaceutical and/or device companies across 219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Potter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,500 | $18 | $25 |
| Blood draw (venipuncture) | 1,537 | $8 | $20 |
| Comprehensive metabolic blood panel | 1,469 | $10 | $105 |
| Lipid panel (cholesterol and triglycerides) | 1,326 | $13 | $90 |
| Office visit, established patient (30-39 min) | 1,175 | $82 | $244 |
| Office visit, established patient (20-29 min) | 615 | $55 | $174 |
| Complete blood count (CBC) with differential | 553 | $8 | $48 |
| Thyroid stimulating hormone (TSH) test | 543 | $16 | $86 |
| Free thyroxine (T4) test | 519 | $9 | $52 |
| Hemoglobin A1c test (diabetes monitoring) | 471 | $10 | $61 |
| Urine microalbumin test (kidney screening) | 415 | $6 | $60 |
| Drug injection, under skin or into muscle | 385 | $10 | $42 |
| Vitamin D level test | 255 | $29 | $249 |
| Flu vaccine administration | 220 | $30 | $35 |
| Flu vaccine, high-dose | 219 | $72 | $76 |
| Annual wellness visit, follow-up | 175 | $119 | $220 |
| Injection, ketorolac tromethamine, per 15 mg | 162 | $0 | $17 |
| Vitamin B-12 level test | 139 | $15 | $70 |
| Folic acid level test | 136 | $14 | $79 |
| Urinalysis with microscopic exam | 125 | $3 | $28 |
| Ceftriaxone antibiotic injection | 124 | $0 | $14 |
| EKG interpretation and report | 111 | $5 | $38 |
| Electrocardiogram (EKG), 12-lead | 110 | $9 | $76 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 104 | $1 | $15 |
| PSA test (prostate cancer screening) | 88 | $18 | $79 |
| Natriuretic peptide (heart and blood vessel protein) level | 81 | $38 | $171 |
| Urine culture, bacterial identification | 77 | $8 | $42 |
| Injection, methylprednisolone acetate, 80 mg | 57 | $8 | $26 |
| Prothrombin time test (blood clotting) | 53 | $4 | $26 |
| Prostate cancer screening; prostate specific antigen test (psa) | 53 | $19 | $79 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 53 | $30 | $110 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 52 | $39 | $155 |
| Bacterial culture, aerobic | 39 | $8 | $40 |
| Antibiotic sensitivity test | 39 | $8 | $58 |
| Ferritin level test (iron stores) | 38 | $13 | $52 |
| Iron level test | 38 | $6 | $39 |
| Transferrin (iron binding protein) level | 38 | $12 | $50 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 32 | $73 | $200 |
| Testosterone (hormone) level, total | 31 | $25 | $105 |
| Screening test for pathogenic organisms | 31 | $6 | $27 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 31 | $16 | $45 |
| Office visit, established patient, complex (40-54 min) | 31 | $139 | $345 |
| Administration of vaccine | 30 | $11 | $48 |
| Magnesium level test | 29 | $7 | $37 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 29 | $48 | $100 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 27 | $281 | $325 |
| Pneumonia vaccine administration | 26 | $30 | $45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 25 | $53 | $324 |
| Thyroid hormone, t3 measurement, free | 23 | $17 | $120 |
| Chest X-ray, 2 views | 20 | $15 | $44 |
| Sed rate test (inflammation marker) | 15 | $3 | $26 |
| Psa (prostate specific antigen) measurement, free | 14 | $18 | $62 |
| C-reactive protein test (inflammation marker) | 13 | $5 | $23 |
| Transitional care management services for problem of at least moderate complexity | 13 | $158 | $280 |
| New patient office visit (45-59 min) | 12 | $114 | $315 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Potter is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Potter experienced with denosumab injection (prolia/xgeva)?
Does Dr. Potter receive payments from pharmaceutical companies?
How do Dr. Potter's costs compare to other internal medicine physicians in Texarkana?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology